High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. [electronic resource]
Producer: 20001103Description: 153-60 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Carmustine -- administration & dosage
- Central Nervous System Neoplasms -- complications
- Chemical and Drug Induced Liver Injury
- Child
- Child, Preschool
- Combined Modality Therapy
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Graft Survival
- Hematologic Diseases -- chemically induced
- Humans
- Infant
- Kidney Diseases -- chemically induced
- Lung Diseases -- chemically induced
- Male
- Middle Aged
- Multiple Organ Failure -- chemically induced
- Nervous System Diseases -- chemically induced
- Survival Rate
- Thiotepa -- administration & dosage
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.